Skin disease treatment patterns study in Italy
Part of Genetic & congenital, Immune system & allergy, Infections, Skin clinical trials.
This study looks at how people with certain immune-related skin diseases are treated in Italy. It will help doctors understand which treatments are used and why.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.
- You were at least 12 years old at your first recorded doctor visit for this condition.
- You are eligible for or are already receiving medicines that work throughout the body (systemic therapies).
- You had at least one doctor visit for this condition between January 2016 and December 2025.
- You have not chosen to opt out of having your medical records used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people view those with certain skin conditions. It aims to understand stigma, which may help improve awareness and support.
This trial is a registry that collects information from adults with plaque psoriasis or psoriatic arthritis who are starting a new biologic or other systemic treatment. It helps researchers understand how these treatments are used in real life and what outcomes they may have.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study looks at how atopic dermatitis (eczema), psoriasis, or other autoimmune skin diseases change over time and how the body responds to anti-inflammatory signals. Your information and—if eligible—samples help researchers find patterns that could guide better treatments.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.